221 related articles for article (PubMed ID: 36166152)
21. Serum inflammatory marker levels in serous macular detachment secondary to diabetic macular edema.
Özata Gündoğdu K; Doğan E; Çelik E; Alagöz G
Eur J Ophthalmol; 2022 Nov; 32(6):3637-3643. PubMed ID: 35225038
[TBL] [Abstract][Full Text] [Related]
22. Reliability of Subjective Assessment of Spectral-Domain OCT Pathologic Features by Multiple Raters in Retinal Vein Occlusion.
Bemme S; Heins A; Lauermann P; Storch MW; Khattab MH; Hoerauf H; Feltgen N; van Oterendorp C
Ophthalmol Sci; 2021 Jun; 1(2):100031. PubMed ID: 36249305
[TBL] [Abstract][Full Text] [Related]
23. Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study.
Zhu R; Xiao S; Zhang W; Li J; Yang M; Zhang Y; Gu X; Yang L
BMC Ophthalmol; 2022 Aug; 22(1):352. PubMed ID: 36038824
[TBL] [Abstract][Full Text] [Related]
24. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of macular morphology and microcirculation in diabetic macular edema patients with serous retinal detachment.
Xu M; Xu H; Li X; Chen F
BMC Ophthalmol; 2022 Jul; 22(1):299. PubMed ID: 35820875
[TBL] [Abstract][Full Text] [Related]
26. Retinal OCT biomarkers associated with reading performance in patients with persistent vs. resolved diabetic macular edema.
Ricardi F; Reccalenda I; Boscia G; Gelormini F; Cimorosi F; Novarese C; Marolo P; Parisi G; Bandello F; Borrelli E; Reibaldi M
Eur J Ophthalmol; 2024 Apr; ():11206721241248682. PubMed ID: 38632942
[TBL] [Abstract][Full Text] [Related]
27. Automatic Segmentation of Retinal Fluid and Photoreceptor Layer from Optical Coherence Tomography Images of Diabetic Macular Edema Patients Using Deep Learning and Associations with Visual Acuity.
Hsu HY; Chou YB; Jheng YC; Kao ZK; Huang HY; Chen HR; Hwang DK; Chen SJ; Chiou SH; Wu YT
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740291
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema.
Chatziralli I; Dimitriou E; Lambadiari V; Kazantzis D; Kapsis P; Theodossiadis G; Theodossiadis P; Sergentanis TN
Semin Ophthalmol; 2022 Jul; 37(5):668-675. PubMed ID: 35468026
[TBL] [Abstract][Full Text] [Related]
29. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
[TBL] [Abstract][Full Text] [Related]
30. Association between Aqueous Humor Cytokines and Structural Characteristics Based on Optical Coherence Tomography in Patients with Diabetic Macular Edema.
Chen Y; Zheng B; Li H; Lin L; Fan Y; Wu M
J Ophthalmol; 2023; 2023():3987281. PubMed ID: 36798724
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment.
Sheu SJ; Lee YY; Horng YH; Lin HS; Lai WY; Tsen CL
Clin Ophthalmol; 2018; 12():1887-1893. PubMed ID: 30310268
[TBL] [Abstract][Full Text] [Related]
32. Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.
Chatziralli I; Theodossiadis G; Dimitriou E; Kazantzis D; Theodossiadis P
Int Ophthalmol; 2020 Oct; 40(10):2441-2448. PubMed ID: 32424527
[TBL] [Abstract][Full Text] [Related]
33. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
[TBL] [Abstract][Full Text] [Related]
34. Factors based on optical coherence tomography correlated with vision impairment in diabetic patients.
Endo H; Kase S; Tanaka H; Takahashi M; Katsuta S; Suzuki Y; Fujii M; Ishida S; Kase M
Sci Rep; 2021 Feb; 11(1):3004. PubMed ID: 33542264
[TBL] [Abstract][Full Text] [Related]
35. Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema.
Qin S; Zhang C; Qin H; Xie H; Luo D; Qiu Q; Liu K; Zhang J; Xu G; Zhang J
Front Physiol; 2021; 12():791442. PubMed ID: 35002773
[No Abstract] [Full Text] [Related]
36. Optical Coherence Tomography Predictors of Favorable Functional Response in Naïve Diabetic Macular Edema Eyes Treated with Dexamethasone Implants as a First-Line Agent.
Meduri A; Oliverio GW; Trombetta L; Giordano M; Inferrera L; Trombetta CJ
J Ophthalmol; 2021; 2021():6639418. PubMed ID: 33833870
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant.
Costanzo E; Giannini D; De Geronimo D; Fragiotta S; Varano M; Parravano M
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835839
[TBL] [Abstract][Full Text] [Related]
38. Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers.
Vujosevic S; Toma C; Villani E; Brambilla M; Torti E; Leporati F; Muraca A; Nucci P; De Cilla S
Transl Vis Sci Technol; 2020 Sep; 9(10):31. PubMed ID: 33062394
[TBL] [Abstract][Full Text] [Related]
39. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
Eraslan S; Yıldırım Ö; Dursun Ö; Dinç E; Orekici Temel G
Turk J Ophthalmol; 2020 Jun; 50(3):163-168. PubMed ID: 32631004
[TBL] [Abstract][Full Text] [Related]
40. Automated evaluation of retinal hyperreflective foci changes in diabetic macular edema patients before and after intravitreal injection.
Wang X; Zhang Y; Ma Y; Kwapong WR; Ying J; Lu J; Ma S; Yan Q; Yi Q; Zhao Y
Front Med (Lausanne); 2023; 10():1280714. PubMed ID: 37869163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
